New Treatments
Transforming TB Treatment
TB Alliance is leading the global effort to develop faster, simpler, and more effective cures for all forms of TB.
Learn More:

Raising our Voices to End TB
TB affects millions – and ending it will require new solutions, stronger investments, and collective action. Communities are at the heart of the fight to end TB: helping to drive awareness, support treatment implementation, reduce stigma, and hold systems accountable. When we work together, we reach more people, close gaps in care, and save lives. This World TB Day, we come together to recognize the power of communities, and the role each of us plays in ending TB.

Meeting with Global TB Stakeholders
Our 2026 Global TB Stakeholders Meeting brought together partners, advocates, and global health leaders with a focus on the promise of and significant progress in establishing a pathway to TB Alliance’s 1×1 vision for the future of TB treatment – one-month treatment for active TB and one-day treatment for latent TB infection.


The Latest from TB Alliance
Impact of BPaL/M: Shorter Care. More Lives Saved. Lower Costs.
Findings from Johns Hopkins University research show that BPaL/M is on track to save 191k lives and US$1.29B by 2034—while boosting treatment completion and success. Read more.
TB By The Numbers

REACHING THOSE IN NEED
Delivering Treatments
TB Alliance’s mission is not complete until new drugs are in the hands of those who need them.
More News:
TRANSFORMING TB TREATMENT
Charting the Course
We’ve all come to know the impact of infectious diseases, but we also know the power of science.
More News:

TB Alliance manages the largest pipeline of new TB drugs in history.
Doris Macharia Elected President of TB Alliance’s Global TB Stakeholders, Joins Board of Directors
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity…
TB Alliance Announces New Collaboration with Novartis to Advance the Research and Development of Telacebec for Leprosy
New collaboration aims to advance innovation for a neglected and stigmatizing disease affecting hundreds of…
TB Alliance and Lupin Announce Collaboration to Advance and Commercialize Telacebec for Multiple Neglected Diseases
Partnership will support the development of investigational drug telacebec for the treatment of tuberculosis, leprosy,…
